tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
OTHER OTC:CARM
US Market
Advertisement

Carisma Therapeutics (CARM) Ownership - Who Owns Carisma Therapeutics?

Compare
1,728 Followers

Carisma Therapeutics (CARM) Ownership Overview

1.59%3.90%0.64%93.87%
3.90% Other Institutional Investors
0.64% ETFs
93.87% Public Companies and
Individual Investors
The ownership structure of Carisma Therapeutics (CARM) stock is a mix of institutional, retail, and individual investors. Approximately 6.13% of the company’s stock is owned by Institutional Investors, and 93.87% is owned by Public Companies and Individual Investors.
The ownership structure of Carisma Therapeutics (CARM) stock is a mix of institutional, retail, and individual investors. Approximately 4.54% of the company’s stock is owned by Institutional Investors, 1.59% is owned by Insiders, and 93.87% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 08, 2025
xxxxxxxxxxxxx
$14246
Oct 03, 2025
xxxxxxxxxxxxx
$122280

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
484,347Insider1.16%167,100
342,628Institution0.82%21,928
235,375Institution0.56%15,064
214,670Institution0.51%13,739
83,036Institution0.20%5,314
30,988Institution0.07%1,983
15,224Institution0.04%974
8,711Institution0.02%558
1,005Institution<0.01%64
150Institution<0.01%10

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
342,628Institution0.82%21,928
214,670Institution0.51%13,739
83,036Institution0.20%5,314
15,224Institution0.04%974
8,711Institution0.02%558
1,005Institution<0.01%64

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
235,375Institution0.56%64,493
30,988Institution0.07%1,735

FAQ

Who Owns Carisma Therapeutics (CARM)?
Currently, no data Available
What percentage of Carisma Therapeutics (CARM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 3.90% of Carisma Therapeutics (CARM) stock is held by institutional investors.
    What percentage of Carisma Therapeutics (CARM) stock is held by retail investors?
    According to the latest TipRanks data, approximately 93.87% of Carisma Therapeutics (CARM) stock is held by retail investors.
      Who owns the most shares of Carisma Therapeutics (CARM)?
      Michael Klichinsky owns the most shares of Carisma Therapeutics (CARM).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis